← Browse by Condition
Medical Condition
neoplasms
Total Trials
14
Recruiting Now
14
Trial Phases
Phase 1, Phase 2, Phase 1, EARLY_Phase 1
ClinicalMetric tracks all active clinical trials for neoplasms sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — neoplasms Clinical Trials
How many clinical trials are currently recruiting for neoplasms?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for neoplasms, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for neoplasms?
neoplasms research spans Phase 1 (5 trials), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a neoplasms clinical trial?
Eligibility criteria for neoplasms trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 5
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05442151
Recruiting
Enrollment
200 pts
Location
Japan
Sponsor
Tadashi Watabe
NCT07276373 Phase 1, Phase 2
Recruiting
Enrollment
50 pts
Location
United States
Sponsor
Corcept Therapeutics
NCT06748820
Recruiting
Enrollment
48 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
NCT07035587
Recruiting
Enrollment
1,200 pts
Location
South Korea
Sponsor
Yonsei University
NCT03911388 Phase 1
Recruiting
Enrollment
24 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06628570
Recruiting
Enrollment
500 pts
Location
United States
Sponsor
Lisa Flowers
NCT04075305
Recruiting
Enrollment
8,000 pts
Location
United States, Austr...
Sponsor
UMC Utrecht
NCT07501780
Recruiting
Enrollment
297 pts
Location
Netherlands
Sponsor
Maastricht University Medical ...
NCT07257640 Phase 1
Recruiting
Enrollment
20 pts
Location
China
Sponsor
Zhejiang University
NCT06346041 EARLY_Phase 1
Recruiting
Enrollment
19 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT05592626 Phase 1, Phase 2
Recruiting
Enrollment
366 pts
Location
United States, Canad...
Sponsor
Marengo Therapeutics, Inc.
NCT00590239
Recruiting
Enrollment
150 pts
Location
United States
Sponsor
Midwest Biomedical Research
NCT07354971
Recruiting
Enrollment
67 pts
Location
United Kingdom
Sponsor
University Hospital Southampto...
NCT07200453
Recruiting
Enrollment
660 pts
Location
Germany
Sponsor
Universitätsklinikum Hamburg-E...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology